drugset / Trial / NCT01723553
Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
NaSingle-groupOpen-labelDiagnostic
Summary
The study is designed to assess the demographic, clinical and imaging associations with the presence of microbleeds in atypical Alzheimer's disease. The primary hypothesis is that cognitive and functional performance will be poorer in atypical Alzheimer's subjects with microbleeds compared to those without microbleeds.
Timeline
- Start
- 2012-11
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C-11 PiB | Diagnostic / imaging agent | 740 mbq | Intravenous |